glp 1 boom GLP-1 Boom: US/UK Restaurants & Supermarkets Roll Out Ozempic-Friendly Food GLP-1 Boom Will Peak in

GLP-1 agonists were originally approved to treat Type 2 Diabetes (T2D) but their most recent incarnations, which consist of both next generation GLP-1s and combinations (Ozempic, Mounjaro, Wegovy, Zepbound), have moved beyond the realm of T2D into the treatment of obesity

Pipes, G

For example, a 2023 study suggests that adolescents who were overweight and took a 60-milligram capsule of saffron each day for 12 weeks had greater reductions in BMI and waist circumference compared to those who took a placebo

the Health Care Collaborative Innovation Foundation Major Projects of Guangzhou City, Guangdong Province, China (201604020189)